APA (7th ed.) Citation

Krackhardt, A., Anliker, B., Hildebrandt, M., Bachmann, M., Eichmüller, S. B., Nettelbeck, D. M., . . . Schüssler-Lenz, M. (2018). Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies: The German Cancer Consortium approach. Cancer immunology immunotherapy, 67(4), . https://doi.org/10.1007/s00262-018-2119-y

Chicago Style (17th ed.) Citation

Krackhardt, Angela, et al. "Clinical Translation and Regulatory Aspects of CAR/TCR-based Adoptive Cell Therapies: The German Cancer Consortium Approach." Cancer Immunology Immunotherapy 67, no. 4 (2018). https://doi.org/10.1007/s00262-018-2119-y.

MLA (9th ed.) Citation

Krackhardt, Angela, et al. "Clinical Translation and Regulatory Aspects of CAR/TCR-based Adoptive Cell Therapies: The German Cancer Consortium Approach." Cancer Immunology Immunotherapy, vol. 67, no. 4, 2018, https://doi.org/10.1007/s00262-018-2119-y.